Peer-influenced content. Sources you trust. No registration required. This is HCN.
OBR Oncology
In a major stride for cervical cancer treatment, the FDA-approved pembrolizumab in combination with CRT demonstrates significant improvement in progression-free survival for FIGO 2014 stage III-IVA patients, marking a pivotal change in therapeutic approaches.
Hematology/Oncology January 22nd 2024
Psychiatry Advisor
The study reveals a significant increase in hospital admissions due to adrenal insufficiency among young women, with psychosocial factors playing a crucial role.
Endocrinology, Diabetes, Metabolism January 3rd 2024
Annals of Internal Medicine
New findings suggest that an evening chronotype in middle-aged nurses is associated with a higher risk of type 2 diabetes, even after accounting for lifestyle factors.
Clinical Pharmacology September 29th 2023
Clinical Advisor
Explore the latest findings on the role of estrogen hormone therapy in Alzheimer’s disease prevention, focusing on the critical timing around menopause for potential intervention.
Neurology September 27th 2023
MDLinx
Explore the latest research illuminating the significant link between sugar-sweetened beverage consumption and liver disease risk in postmenopausal women—evidence that could inform your nutritional guidance to patients.
Family Medicine/General Practice September 25th 2023
The New England Journal of Medicine
Examine the evidence critically: the USPSTF’s new mammography guidelines raise significant questions regarding both efficacy and ethics.
Internal Medicine September 25th 2023